G210-0125 Screening compound: N-[2-(azepan-1-yl)ethyl]-3-(3,4-diethoxyphenyl)-2,7-dimethylpyrazolo[1,5-a]pyrimidine-6-carboxamide

G210-0125 Screening compound: N-[2-(azepan-1-yl)ethyl]-3-(3,4-diethoxyphenyl)-2,7-dimethylpyrazolo[1,5-a]pyrimidine-6-carboxamide
G210-0125 Screening compound: N-[2-(azepan-1-yl)ethyl]-3-(3,4-diethoxyphenyl)-2,7-dimethylpyrazolo[1,5-a]pyrimidine-6-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G210-0125
N-[2-(azepan-1-yl)ethyl]-3-(3,4-diethoxyphenyl)-2,7-dimethylpyrazolo[1,5-a]pyrimidine-6-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G210-0125

Molecular Formula

C27H37N5O3 (C27 H37 N5 O3)

Compound Name

N-[2-(azepan-1-yl)ethyl]-3-(3,4-diethoxyphenyl)-2,7-dimethylpyrazolo[1,5-a]pyrimidine-6-carboxamide

IUPAC name

N-[2-(azepan-1-yl)ethyl]-3-(34-diethoxyphenyl)-27-dimethylpyrazolo[15-a]pyrimidine-6-carboxamide

SMILES

CCOc(ccc(-c1c2ncc(C(NCCN3CCCCCC3)=O)c(C)n2nc1C)c1)c1OCC

InChI

InChI=1S/C27H37N5O3/c1-5-34-23-12-11-21(17-24(23)35-6-2)25-19(3)30-32-20(4)22(18-29-26(25)32)27(33)28-13-16-31-14-9-7-8-10-15-31/h11-12,17-18H,5-10,13-16H2,1-4H3,(H,28,33)

InChI Key

KMDCRQSUGAQJHC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14986437

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

479.62

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.962

Distribution Coefficient, logD

1.985

Water Solubility, LogSw

-3.22

Polar Surface Area

63.778

Acid Dissociation Constant (pKa)

12.21

Base Dissociation Constant (pKb)

8.33

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

51.90

G210-0125 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with G210-0125 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G210-0125?
Check Price and Availability of G210-0125, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G210-0125 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G210-0125
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G210-0125
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G210-0125 available by request